Provectus Biopharmaceuticals, Inc.
PVCT- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000315545
No open-market purchases or sales by Provectus Biopharmaceuticals, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $8.97K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Provectus Biopharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 8 | 7 | −1 |
| Shares | 259.0K | 2.64M | +2.38M (+919.1%) |
| Value | $16.0K | $146.0K | +$130.0K (+812.5%) |
New holders (1)
Institutions that held Provectus Biopharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sunflower Bank, N.A. | 2,411,871 | $133.0K | 0.02% |
Sold out (2)
Institutions that held Provectus Biopharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Cutter & CO Brokerage, Inc. | 29,750 | $2.00K |
| LBMC Investment Advisors, LLC | 22,000 | $1.00K |